Cargando…

Risk factors associated with readmissions of patients with severe mental disorders under treatment with antipsychotics

BACKGROUND: The aim of this study was to assess the risk of readmission in patients with severe mental disorders, compare it between patients using different types of antipsychotics and determine risk factors for psychiatric readmission. METHODS: Medical records of a non-concurrent cohort of 625 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Portela, Ronaldo, Wainberg, Milton Leonard, Castel, Saulo, de Oliveira, Helian Nunes, Ruas, Cristina Mariano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931964/ https://www.ncbi.nlm.nih.gov/pubmed/35300649 http://dx.doi.org/10.1186/s12888-022-03794-6

Ejemplares similares

Health-related quality of life in patients treated with atypical antipsychotics
por: de Almeida, Juliana L., et al.
Publicado: (2020)

Judicialização de produtos à base de canabidiol no Brasil: uma análise de 2019 a 2022
por: Portela, Ronaldo, et al.
Publicado: (2023)

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil
por: Barbosa, Wallace Breno, et al.
Publicado: (2018)

Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017)

Ending HIV, hepatitis B, and hepatitis C: what about people with severe mental illness?
por: Wainberg, Milton, et al.
Publicado: (2017)

Impact of Antipsychotic Use on Readmission Rates in Children and Adolescents With Autism Spectrum Disorder and Irritability
por: Kompella, Sindhura, et al.
Publicado: (2022)

T229. ANTIPSYCHOTIC DRUG USE AND THYROID FUNCTION IN PATIENTS WITH SEVERE MENTAL DISORDERS
por: Iversen, Trude, et al.
Publicado: (2018)

Pharmacological Mechanisms Underlying the Association of Antipsychotics with Metabolic Disorders
por: MIRON, ILEANA CRISTINA, et al.
Publicado: (2014)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Sexual stigma, attachment difficulties, and emotional dysregulation among patients with severe mental illness
por: Scanavino, Marco D.T., et al.
Publicado: (2020)

Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia
por: Strømme, Maria F., et al.
Publicado: (2022)

Predictors of Length of Hospitalization and Impact on Early Readmission for Mental Disorders
por: Gentil, Lia, et al.
Publicado: (2022)

Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder
por: Chou, Fabienne, et al.
Publicado: (2016)

Persons with severe mental health conditions should be included as a key population in HIV programmes
por: Freeman, Melvyn C., et al.
Publicado: (2023)

Magic Bullets for Mental Disorders: The Emergence of the Concept of an “Antipsychotic” Drug
por: Moncrieff, Joanna
Publicado: (2013)

An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
por: Prokopez, Cintia R., et al.
Publicado: (2021)

Mental health disorders and readmissions following acute myocardial infarction in the United States
por: Sreenivasan, Jayakumar, et al.
Publicado: (2022)

Primary care and mental health: Where do we go from here?
por: Moise, Nathalie, et al.
Publicado: (2021)

World Mental Health Day 2023: We must leave no one behind in the response to HIV and mental health
por: Wainberg, Milton L., et al.
Publicado: (2023)

Barriers to mental healthcare and treatment for people living with HIV in the Asia‐Pacific
por: Sohn, Annette H, et al.
Publicado: (2018)

Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
por: Reponen, Elina J., et al.
Publicado: (2021)

The Electronic Mental Wellness Tool as a Self-Administered Brief Screening Instrument for Mental Disorders in the General Spanish Population during the Post-COVID-19 Era
por: Martinez-Nicolas, Ismael, et al.
Publicado: (2023)

Cultural adaptation of psychological interventions for people with mental disorders delivered by lay health workers in Africa: scoping review and expert consultation
por: Mabunda, Dirceu, et al.
Publicado: (2022)

Use of antipsychotics in the treatment of major depressive disorder in an outpatient mental health center
por: Garnier, Carolina, et al.
Publicado: (2010)

Optimization of antipsychotic use in the elderly with severe mental illness; a review of three cases.
por: Izquierdo De La Puente, A., et al.
Publicado: (2023)

National database study on the use of long‐acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan
por: Usuki, Masato, et al.
Publicado: (2020)

High‐dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital
por: Yamada, Yuji, et al.
Publicado: (2020)

Suicide in Global Mental Health
por: Lovero, Kathryn L., et al.
Publicado: (2023)

Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation
por: Dickson, Matthew C., et al.
Publicado: (2022)

Readmissions performance and penalty experience of safety-net hospitals under Medicare’s Hospital Readmissions Reduction Program
por: Banerjee, Souvik, et al.
Publicado: (2022)

S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020)

Use of antipsychotics in the treatment of depressive disorders
por: Wang, Ping, et al.
Publicado: (2013)

Application of Antipsychotic Drugs in Mood Disorders
por: Rybakowski, Janusz K.
Publicado: (2023)

Antipsychotic monitoring in dementia: quality of completion of antipsychotic monitoring forms in an older adult mental health service
por: Anderson, Helen, et al.
Publicado: (2022)

Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis
por: Torres, Ulysses S, et al.
Publicado: (2013)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
por: González-Rodríguez, A., et al.
Publicado: (2021)

Ethical Considerations for Disseminating Research Findings on Gender-Based Violence, Armed Conflict, and Mental Health: A Case Study from Rural Uganda
por: Mootz, Jennifer J., et al.
Publicado: (2019)

Inaugural Readmission Penalties for Total Hip and Total Knee Arthroplasty Procedures Under the Hospital Readmissions Reduction Program
por: Li, Benjamin Y., et al.
Publicado: (2019)

Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders
por: Vassilopoulou, Emilia, et al.
Publicado: (2021)

The pharmacogenetics of the new-generation antipsychotics – A scoping review focused on patients with severe psychiatric disorders
por: Vasiliu, Octavian
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oqci5tu0lr46sm9blkfvq8s2lh